AstraZeneca recalls Fasenra (benralizumab) 30 mg/mL pre-filled syringes due to lack of sterility assurance. This may cause infections if used.
Lack of Assurance of Sterility:
AstraZeneca is recalling Fasenra injections because they might not be sterile, which could lead to infections. People with prescribed use should stop using the product and contact their doctor.
The injections may not be sterile, meaning they could contain harmful bacteria or other contaminants. If used, this could cause infections, especially in people with weakened immune systems.
People prescribed Fasenra injections by a doctor are affected. Those with compromised immune systems are at higher risk of infection.
Check for the product name Fasenra (benralizumab) 30 mg/mL, single-dose pre-filled syringe. Look for NDC code 0310-1730-30 and lot number YJ0152.
Discard the recalled Fasenra injection immediately if you have it.
The product is not safe to use as it may not be sterile, which could cause infections.
Check for the NDC code 0310-1730-30 and lot number YJ0152 on the syringe label.
Discard the product immediately and contact your doctor for alternative treatment.
We’ve drafted a message you can send AstraZeneca to request your refund or repair — edit it as you like.
Subject: Recall D-0028-2026 — AstraZeneca AstraZeneca Hello, I own a AstraZeneca that is covered by recall D-0028-2026 from AstraZeneca. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
